Beta-adrenergic receptor antagonists and chronic heart failure in children

References

• AuslenderMArtmanMOverview of the management of pediatric heart failureProgr Pediatr Cardiol20001123141
   PubMed Web of Science ®Google Scholar
• AzekaEFranchini RamiresJABocchiEADelisting of infants and children from the heart transplantation waiting list after Carvedilol treatmentJ Am Coll Cardiol2002402034812475466
   PubMed Web of Science ®Google Scholar
• BlumeEDCanterCESpicerRProspective single-arm protocol of carvedilol in children with ventricular dysfunctionPediatr Cardiol2006273364216596434
   PubMed Web of Science ®Google Scholar
• BristowMRGilbertEMAbrahamWTCarvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA InvestigatorsCirculation1996942807168941106
   PubMed Web of Science ®Google Scholar
• BristowMRMechanism of action of beta-blocking agents in heart failureAm J Cardiol19978026L40L
   PubMed Web of Science ®Google Scholar
• BrunsLAKichuk ChrisantMLamourJMCarvedilol as therapy in pediatric heart failure: An initial multicenter experienceJ Pediatr20011385051111295713
   PubMed Web of Science ®Google Scholar
• BuchhornRHulpke-WetteMRuschexskiWEffects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital heart diseaseCardiol Young200313364312691286
   PubMed Web of Science ®Google Scholar
• BullingaJRAlharethiRSchramMSChanges in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failureJ Card Fail200511693916360965
   PubMed Web of Science ®Google Scholar
• ChenHHSchrierRWPathophysiology of volume overload in acute heart failure syndromesAm J Med200611912 Suppl 1S11617113395
   PubMed Web of Science ®Google Scholar
• CIBIS Investigators and CommitteesA randomized trial of beta-blockade in heart failure The Cardiac Insufficiency Bisoprolol Study_CIBISCirculation1994901765737923660
   PubMed Web of Science ®Google Scholar
• CIBIS-IIThe cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trialLancet199935391310023943
   PubMed Web of Science ®Google Scholar
• ClarkBJ3rdTreatment of heart failure in infants and childrenHeart Dis200023546111728282
   PubMedGoogle Scholar
• ClelandJGFColettaAPNikitinNPClinical trials update from the American College of Cardiology: darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELANDEur J Heart Fail20068326916698503
   PubMed Web of Science ®Google Scholar
• ColucciWSPackerMBristowMRfor the Carvedilol Heart Failure Study GroupCarvedilol inhibits clinical progression in patients with mild symptoms of heart failureCirculation199694280068941105
   PubMed Web of Science ®Google Scholar
• De LucaLAbrahamWTFonarowGCCongestion in acute heart failure syndromes: importance of early recognition and treatmentRev Cardiovasc Med20067697416915125
   PubMed Web of Science ®Google Scholar
• FeuersteinGZBrilARuffoloRRJrProtective effects of carvedilol in the myocardiumAm J Cardiol19978041L45L
   PubMed Web of Science ®Google Scholar
• FrancisGSPathophysiology of chronic heart failureAm J Med2001110Suppl 7A37S46S11334774
   PubMedGoogle Scholar
• GheorgiadeMFilippatosGDe LucaLCongestion in acute heart failure syndromes: an essential target of evaluation and treatmentAm J Med200611912 Suppl 1S310
   Web of Science ®Google Scholar
• GiardiniAFormigariRBronzettiGModulation of neurohormonal activity after treatment of children in heart failure with carvedilolCardiol Young200313333614694952
   PubMed Web of Science ®Google Scholar
• HjalmarsonAGoldsteinSFagerbergBEffects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF study groupJAMA2000283129530210714728
   PubMed Web of Science ®Google Scholar
• HochMNetzHHeart failure in pediatric patientsThorac Cardiov Surg200553Suppl 2S129S134
   PubMed Web of Science ®Google Scholar
• KametaniRMiuraTHaradaNCarvedilol inhibits mitochondrial oxygen consumption and superoxide production during calcium overload in isolated heart mitochondriaCirc J200670321616501300
   PubMed Web of Science ®Google Scholar
• KawaiKQinFShiteJImportance of antioxidant and antiapoptotic effects of β-receptor blockers in heart failure therapyAm J Physiol Heart Circ Physiol2004287H10031215105169
   PubMed Web of Science ®Google Scholar
• KayJDColanSDGrahamTPCongestive heart failure in pediatric patientsAm Heart J2001142923811685182
   PubMed Web of Science ®Google Scholar
• KayeDMJohnstonLVaddadiGMechanisms of carvedilol action in human congestive heart failureHypertension20013712162111358931
   PubMed Web of Science ®Google Scholar
• KrumHNinioDMacDonaldPBaseline predictors of tolerability to carvedilol in patients with chronic heart failureHeart200084615911083738
   PubMed Web of Science ®Google Scholar
• LäerSMirTSBehnFCarvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parametersAm Heart J20021439162212040358
   PubMed Web of Science ®Google Scholar
• LechatPPackerMChalonSClinical effects of beta-adrenergic blockade in chronic heart failure : a meta-analysis of double-blind, placebo-controlled randomized trialsCirculation1998981184919743509
   PubMed Web of Science ®Google Scholar
• LowesBDGillEAAbrahamWTEffects of carvedilol on left ventricular mass, chamber geometry and mitral regurgitation in chronic heart failureAm J Cardiol1999831201510215284
   PubMed Web of Science ®Google Scholar
• Merit-HFEffects of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)Lancet19993532001710376614
   PubMed Web of Science ®Google Scholar
• MetraMTorp-PedersonCSwedbergKInfluence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trialEur Heart J20052622596816040619
   PubMed Web of Science ®Google Scholar
• NagatsuMSpinaleFGKoideMBradycardia and the role of β-blockade in the amelioration of left ventricular dysfunctionCirculation2000101653910673258
   PubMed Web of Science ®Google Scholar
• NakamuraKKusanoKNakamuraYCarvedilol decreases elevated oxidative stress in human failing myocardiumCirculation200210528677112070115
   PubMed Web of Science ®Google Scholar
• NikolaidisLAPoornimaIParikhPThe effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathyJ Am Coll Cardiol20064718718116682315
   PubMed Web of Science ®Google Scholar
• O’LaughlinMPCongestive heart failure in childrenPediatr Clin North Am1999462637310218074
   PubMed Web of Science ®Google Scholar
• PackerMBristowMRCohnJNThe effects of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study GroupN Engl J Med19963341349558614419
   PubMed Web of Science ®Google Scholar
• PackerMFowlerMBRoeckerEBEffects of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) studyCirculation200210621949912390947
   PubMed Web of Science ®Google Scholar
• PackerMColucciWSSackner-BernsteinJDDouble-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective randomized evaluation of carvedilol on symptoms and exerciseCirculation199694279398941104
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPASwedbergKClelandJGComparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomised controlled trialLancet200336271312853193
   PubMed Web of Science ®Google Scholar
• QuaifeRAGilbertEMChristianPEEffects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathyAm J Cardiol199778779848857482
   PubMed Web of Science ®Google Scholar
• RatnapalanSGriffithsKMoldovan CosteiADigoxin-carvedilol interactions in childrenJ Pediatr2003142572412756393
   PubMed Web of Science ®Google Scholar
• ReikenSWehrensXHTVestJAβ-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failureCirculation200310724596612743001
   PubMed Web of Science ®Google Scholar
• RossRDMedical management of chronic heart failure in childrenAm J Cardiovasc Drugs20011374414728050
   PubMedGoogle Scholar
• RusconiPGomez-MarinORossique-GonzalezMCarvedilol in children with cardiomyopathy: 3-year experience at a single institutionJ Heart Lung Transpl2004238328
   PubMed Web of Science ®Google Scholar
• SabbahHNThe cellular and physiologic effects of beta blockers in heart failureClin Cardiol199922Suppl 2V162010526699
   PubMed Web of Science ®Google Scholar
• Sackner-BernsteinJDManciniDMRationale for treatment of patients with chronic heart failure with adrenergic blockadeJ Am Med Assoc199527414627
   Web of Science ®Google Scholar
• ShaddyRECurtinELSowerBThe pediatric randomized carvedilol trial in children with chronic heart failure: Rationale and design for The Pediatric Randomized Carvedilol Trial in Children with Heart Failure StudyAm Heart J2002144383912228773
   PubMed Web of Science ®Google Scholar
• ShaddyRETaniLYGiddingSSBeta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experienceJ Heart Lung Transpl19991826974
   PubMed Web of Science ®Google Scholar
• ShaddyREBeta-adrenergic blockers in the treatment of pediatric heart failureProgr Pediatr Cardiol2000121138
   PubMedGoogle Scholar
• ShaddyREOptimizing treatment for chronic congestive heart failure in childrenCrit Care Med200129SupplS237S24011593067
   PubMed Web of Science ®Google Scholar
• SpicerRLCarvedilol – new dimension in pediatric heart failure therapyJ Pediatr2001138457811295704
   PubMed Web of Science ®Google Scholar
• SternHWeilJGenzTVogtWCaptopril in children with dilated cardiomyopathy: acute and long-term effects in prospective study of hemodynamic and hormonal effectsPediatr Cardiol1990112282406705
   PubMed Web of Science ®Google Scholar
• WaagsteinFBristowMRSwedbergKBeneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy_MDC. Trial Study GroupLancet1993342144167902479
   PubMed Web of Science ®Google Scholar
• WilliamsRVTaniLYShaddyREIntermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunctionJ Heart Lung Transpl2002219069
   PubMed Web of Science ®Google Scholar